The role of innate lymphoid cells in the pathogenesis of rheumatic diseases
Сибирский научный медицинский журнал · 05.05.2026 · 46 (2) · 21-31
DOI: 10.18699/ssmj20260203 ↗Kurz gefasst
Fachartikel in der Zeitschrift Сибирский научный медицинский журнал, online erschienen am 05.05.2026. Verfasst von V. S. Ovchinnikov und 3 weiteren Autor:innen. Die Arbeit nennt 46 Literaturangaben.
Abstract (Originalsprache)
The aim of the study is to systematize current data on the role of innate lymphoid cells (ILC) in the pathogenesis of rheumatic diseases such as rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, systemic sclerosis, and systemic lupus erythematosus. Material and methods. A systematic review of the literature was conducted using data from PubMed, Scopus, and eLIBRARY.RU databases. The following keywords were used: «innate lymphoid cells», «ILC», «rheumatoid arthritis», «psoriatic arthritis», «spondyloarthritis», «systemic sclerosis», «systemic lupus erythematosus». This review presents up-to-date information on the role of various ILC subpopulations in the pathogenesis of rheumatic diseases, the maintenance of chronic inflammation in joints and other target organs, the involvement of ILC in the regulation of pathological remodeling of bone and cartilage tissue, as well as the phenotypic and functional plasticity of ILC. The perspectives of therapeutic modulation of ILC using inhibitors of pro-inflammatory cytokines and Janus kinases (JAK inhibitors) are discussed. Conclusions . ILC play a crucial role in the pathogenesis of rheumatological diseases such as rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, systemic sclerosis, and systemic lupus erythematosus. ILC regulate inflammation and the immune response, affecting joint tissue destruction and osteoclastogenesis. Under certain conditions, ILC can adapt to changes in the microenvironment, offering opportunities for the development of targeted therapeutic approaches. The use of drugs targeting ILC, such as JAK-STAT and IL-17 inhibitors, has shown encouraging results, making it a promising avenue for therapeutic interventions aimed at this immune cell subpopulation. However, further research is needed to deepen the understanding of ILC mechanisms and refine therapeutic strategies.
Zitieren
APA
Ovchinnikov, V. S., Sevastyanov, P. V., Boeva, O. S., & Korolev, M. A. (2026). The role of innate lymphoid cells in the pathogenesis of rheumatic diseases. Сибирский научный медицинский журнал, 46(2), 21-31. https://doi.org/10.18699/ssmj20260203
Vancouver
Ovchinnikov VS, Sevastyanov PV, Boeva OS, Korolev MA. The role of innate lymphoid cells in the pathogenesis of rheumatic diseases. Сибирский научный медицинский журнал. 2026;46(2):21-31. doi:10.18699/ssmj20260203
BibTeX
@article{Ovchinnikov2026,
author = {Ovchinnikov, V. S. and Sevastyanov, P. V. and Boeva, O. S. and Korolev, M. A.},
title = {The role of innate lymphoid cells in the pathogenesis of rheumatic diseases},
journal = {Сибирский научный медицинский журнал},
year = {2026},
volume = {46},
number = {2},
pages = {21--31},
doi = {10.18699/ssmj20260203}
}
EUVIMED